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n many cell types agonist-receptor activation leads to a
rapid and transient release of Ca
 
2
 

 
 from intracellular stores
via activation of inositol 1,4,5 trisphosphate (InsP
 
3
 
) receptors
(InsP
 
3
 
Rs). Stimulated cells activate store- or receptor-operated
calcium channels localized in the plasma membrane, allow-
ing entry of extracellular calcium into the cytoplasm, and
thus replenishment of intracellular calcium stores. Calcium
entry must be finely regulated in order to prevent an excessive
intracellular calcium increase. Junctate, an integral calcium
binding protein of endo(sarco)plasmic reticulum membrane,
(a) induces and/or stabilizes peripheral couplings between
I
 
the ER and the plasma membrane, and (b) forms a supra-
molecular complex with the InsP
 
3
 
R and the canonical
transient receptor potential protein (TRPC) 3 calcium en-
try channel. The full-length protein modulates both ago-
nist-induced and store depletion–induced calcium entry,
whereas its NH
 
2
 
 terminus affects receptor-activated calcium
entry. RNA interference to deplete cells of endogenous
junctate, knocked down both agonist-activated calcium re-
lease from intracellular stores and calcium entry via TRPC3.
These results demonstrate that junctate is a new protein
involved in calcium homeostasis in eukaryotic cells.
 
Introduction
 
The overall importance of Ca
 
2
 

 
 signaling in a variety biological
functions is firmly established. Agonist-receptor interactions
cause a rapid and transient release of Ca
 
2
 

 
 from ER stores
via inositol 1,4,5 trisphosphate (InsP
 
3
 
) receptor (InsP
 
3
 
R)
activation, which in turn stimulates numerous cellular responses
ranging from secretion to gene expression (Clapham, 1995;
Berridge et al., 2000). Stimulation of InsP
 
3
 
R and/or deple-
tion of intracellular calcium stores, activate a set of receptor-
or store-operated calcium channels localized on the plasma
membrane, allowing entry of extracellular calcium into the
cytoplasm and thus replenishment of intracellular calcium
stores (Irvine, 1990; Zhu et al., 1996; Kiselyov et al., 1998;
Ma et al., 2000; Elliot, 2001; Putney et al., 2001). The
canonical transient receptor potential proteins (TRPCs)
constitute some of the calcium influx channels. Several
mechanisms have been put forward to explain how calcium
entry occurs (for reviews see Patterson et al., 1999; Elliot,
2001; Putney et al., 2001; Clapham, 2003). The “conforma-
tional coupling” model predicts that calcium entry occurs
via a mechanism similar to that underlying excitation-
contraction coupling of skeletal muscle (Irvine, 1990; Kiselyov
et al., 2000). The latter event involves interaction between
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the ryanodine receptor in the sarcoplasmic reticulum mem-
brane and the dihydropyridine receptor on the plasma
membrane, but a number of accessory proteins are also in-
volved in excitation-contraction coupling (Marty et al.,
1994; Nakai et al., 1996; Franzini-Armstrong and Protasi,
1997). By analogy, the InsP
 
3
 
R might be localized vis a vis
the plasma membrane in microdomains of the ER endowed
with different protein components which could be in-
volved in the mechanisms of calcium entry (Tang et al.,
2001). As part of a comprehensive search of proteins in-
volved in excitation-contraction coupling, we identified
junctate, a 33-kD integral membrane calcium binding pro-
tein (21 moles of Ca
 
2
 

 
 per mole of protein, 
 
K
 
d
 
 217 
 

 
M)
of sarco(endo)plasmic reticulum membranes which is ex-
pressed in a variety of tissues (Dinchuk et al., 2000; Treves
et al., 2000; Hong et al., 2001). The first 78 residues of
junctate are identical to those of junctin; the latter protein
is found in the sarcoplasmic reticulum of heart and skeletal
muscle, and forms a quaternary complex with the ryano-
dine receptor, calsequestrin, and triadin (Zhang et al.,
1997). Overexpression of junctate in COS-7 cells affects
calcium release via InsP
 
3
 
R activation (Treves et al., 2000).
In this work, we demonstrate that junctate is part of a su-
pramolecular complex with InsP
 
3
 
Rs and TRPC3 and mod-
ulates calcium entry through receptor- and store-activated
channels.
 
Results
 
The NH
 
2
 
-domain of junctate interacts with the InsP
 
3
 
R
 
The present work was undertaken in order to determine
whether InsP
 
3
 
R and junctate interact in vivo. We found that
junctate: (a) is an integral protein component of bovine cer-
ebellum microsomal membranes (Fig. 1, top, lanes 1 and 2),
a tissue fraction enriched in InsP
 
3
 
R; and (b) coimmunopre-
cipitates with InsP
 
3
 
R (Fig. 1, top, lane 6).
Junctate is made up of a short NH
 
2
 
-terminal cytoplasmic
domain, followed by a hydrophobic transmembrane domain
and a lumenal COOH-terminal calcium-binding domain.
To define the domain of junctate involved in the interaction
with the InsP
 
3
 
R, we performed pull-down experiments with a
synthetic biotinylated peptide corresponding to the cytoplas-
mic NH
 
2
 
-domain and with a fusion protein containing the
COOH-terminal domain. The NH
 
2
 
-domain of junctate spe-
cifically binds to InsP
 
3
 
R types 1 and 2 in rabbit brain mi-
crosomes (Fig. 1 A, lanes 3 and 6, respectively), and to type 3
InsP
 
3
 
R present in rabbit lung microsomes. (Fig. 1 B, lane 3).
The InsP
 
3
 
R did not interact either with (a) a peptide corre-
sponding to the scrambled sequence of the NH
 
2
 
-terminal do-
main (Fig. 1 C, lane 3) or (b) a fusion protein encompassing
the COOH-terminal domain of junctate (Fig. 1 D, lane 3).
 
Junctate affects agonist-induced calcium release and 
receptor-activated calcium entry
 
We investigated the role of junctate (a) on the regulation of
InsP
 
3
 
-mediated agonist induced calcium release from intra-
cellular stores and (b) on calcium entry elicited in response
to InsP
 
3
 
R activation, i.e., Ca
 
2
 

 
-influx mediating refilling of
the intracellular calcium stores. ATP stimulation of the
PLC/InsP
 
3
 
 pathway in COS-7 cells in the presence of nomi-
nally calcium-free Krebs-Ringer, caused an immediate rapid
rise in the [Ca
 
2
 

 
]
 
i
 
 followed by a slow decline to resting levels
(Fig. 2, A–D). COS-7 cells overexpressing full-length junc-
tate (junctate-EGFP) exhibited a significant increase in peak
ATP-induced Ca
 
2
 

 
 release (mean 
 

 
 SEM was 20% 
 
 
 
2,
 
n 
 

 
 57; **P 
 

 
 0.0004; Fig. 2 E). The transient increases in
[Ca
 
2
 

 
]
 
i
 
 of cells transfected with either NH
 
2
 
-terminal (NH
 
2
 
-
Figure 1. Coimmunoprecipitation of InsP3R with 
antijunctate Ab. (Top) Proteins present in the total 
microsomal fraction (lane 1, 10 g protein) or 
integral membrane proteins extracted with 100 mM 
Na2CO3 (lane 2, 10 g protein) of bovine cerebella 
were stained with antijunctate Ab. Solubilized mi-
crosomal proteins were incubated in the absence 
(lanes 3 and 4) and in the presence of affinity-purified 
antijunctate Ab (lanes 5 and 6). Proteins complexing 
with junctate were coimmunoprecipitated with 
protein-A Sepharose beads and stained with anti-
InsP3R Ab (lanes 3–6). Lanes 3 and 5, void; lanes 4 
and 6, proteins bound to Protein–A Sepharose 
beads. (Bottom) Peptide pull-down experiments. 
(A) Triton X-100–solubilized rabbit brain microsomes 
stained with antibodies against type 1 InsP3R (lane 
1, void; lane 2, last wash; lane 3, beads) and type 2 
InsP3R (lane 4, void; lane 5, last wash; lane 6, 
beads). (B) Lung microsomes stained with type 3 
InsP3R Ab (lane 1, void; lane 2, last wash; lane 3, 
beads). (C) Brain microsomes were incubated with 
a peptide corresponding to the scrambled sequence 
of the NH2-terminal domain of junctate and stained 
with anti-InsP3R Abs (lane 1, void; lane 2, last wash; 
lane 3, beads). (D) Brain microsomes were incubated 
with a GST fusion protein containing the COOH-
terminal domain of junctate and stained with anti-
InsP3R Ab (lane 1, void; lane 2, last wash; lane 3 
glutathione-Sepharose beads).
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TM-EGFP) or COOH-terminal (EGFP-TM-COOH) do-
mains of junctate were not significantly different from those
observed in mock-transfected cells, excluding the possibility
that the increases in calcium release observed in cells trans-
fected with full-length junctate, is due to nonspecific cellular
responses secondary to overexpression of recombinant pro-
teins. Junctate overexpression did not affect the amount of
InsP
 
3
 
R expressed, as determined by Western blot analysis
(unpublished data). To establish if the effect of the different
junctate constructs on calcium transients were due to in-
creases of releasable calcium from ER, we determined the
amount of calcium released from the stores by treating trans-
fected COS-7 cells with the sarcoplasmic and ER Ca
 
2
 

 
ATPase
(SERCA) inhibitor Di-tert-butylhydroquinone (
 
t
 
-BuBHQ)
in the presence of nominally calcium-free medium. Overex-
pression of either full-length junctate, or of its COOH-ter-
minal calcium binding domain significantly increased the
 
t-
 
BuBHQ releasable Ca
 
2
 

 
; on the other hand in cells overex-
pressing the NH
 
2
 
-terminal domain, the 
 
t-
 
BuBHQ releas-
able-Ca
 
2
 

 
 was not different from control COS-7 cells (Fig. 2
G). The ER-free [Ca
 
2
 

 
] of mock-transfected cells and cells
overexpressing junctate were not significantly different (the
means 
 

 
 SD were 456 
 

 
 54 and 412 
 

 
 27 
 

 
M, respec-
tively; 
 
n 
 
 
 
47; 
 
t
 
 test, P 
 
 
 
0.497). These results indicate that
overexpression of the COOH-terminal Ca
 
2
 

 
-binding do-
main of junctate increases the releasable calcium present in
the intracellular stores of COS-7 cells.
Cells expressing cDNA either for the full-length junctate
or for the NH
 
2
 
-terminal cytoplasmic domain exhibited a
larger calcium entry (P 
 
 
 
0.001) compared with mock-
transfected COS-7 cells: the increases were 37% 
 

 
 4; 
 
n 
 

 
 57
(mean 
 

 
 SEM) for cells overexpressing the full-length junc-
tate (Fig. 2 F) and 57% 
 

 
 4.5; 
 
n 
 

 
 55 (mean 
 

 
 SEM) for
cells overexpressing the cytoplasmic domain (Fig. 2 F). Cal-
cium entry in cells transfected with the COOH-terminal do-
main of junctate was not different from that of mock-trans-
fected cells. The effect of junctate on calcium entry is not
due to nonspecific leak of calcium through the plasma mem-
Figure 2. Junctate affects agonist-induced peak 
calcium release, receptor-activated calcium entry 
and t-BuBHQ-sensitive calcium pools. (A–D) Indo-1–
loaded COS-7 cells were flushed with a solution 
containing 100 M ATP in nominally Ca2-free 
Krebs-Ringer; once the [Ca2]i had returned to 
resting levels, calcium influx was stimulated by 
addition of 2 mM Ca2 in the presence of 100 M 
ATP in Krebs-Ringer. Each record is from a single 
cell. Calcium influx was blocked by exposing the 
cell to a solution containing 2 mM lanthanum. 
(E and F) Calcium released and calcium entry peak 
amplitudes are presented as a percentage of the 
same changes in mock-transfected cells (mean  
SEM; n  single cells from four different transfec-
tions). (G) COS-7 cells were loaded with 5 M 
fura-2/AM and then perfused with 50 M t-BuBHQ 
in nominally Ca2-free Krebs-Ringer. Total amount 
of calcium released was measured by calculating 
the integral of the calcium transient, using the 
Origin computer program software. Values are 
mean  SEM; n  number of cells from three 
different transfections; **, indicates statistically 
significant difference from mock-transfected cells. 
a.u., arbitrary units.
540 The Journal of Cell Biology | Volume 166, Number 4, 2004
brane induced by protein overexpression, because lantha-
num or gadolinium, two cations that have been shown to in-
hibit store-operated Ca2 entry (Kwan et al., 1990; Trebak
et al., 2002), caused the [Ca2]i to return to resting levels in
all transfected cells we examined (Fig. 2, A–D, traces).
We also determined whether the potentiation of receptor
activated calcium entry by junctate requires PLC activation
and/or generation of diacylglycerol by studying the charac-
teristics of calcium entry after application of U73122, which
is a specific inhibitor of PLC (Smith et al., 1990; Fig. 3 A).
The presence of 10 M U73122 almost completely abol-
ished calcium influx in both mock-transfected COS-7 cells
and cells transfected with the full-length junctate-EGFP
(Fig. 3, A and C). Under similar experimental conditions,
the inactive analogue U73343 did not block calcium influx
(not depicted).
Figure 3. Junctate requires activation of PLC to 
modulate calcium entry. Cells were first stimulated 
with ATP; after the intracellular Ca2 concentration 
returned to basal the cells were flushed for 40 s 
with the PLC-inhibitor U73122 and with 2-APB. 
Traces show the recordings of the calcium influx 
stimulated by addition of 2 mM calcium in the 
presence of ATP plus 10 M of PLC-inhibitor 
U73122 or 75 M of 2-APB.
Figure 4. Junctate modulates calcium entry 
mediated by depletion of the ER independently 
of receptor activation. (A–D) Transfected cells 
were loaded with 5 M indo-1/AM in the presence 
of 1 mM EGTA. Cells were exposed to 50 M 
t-BuBHQ in the presence of nominally Ca2-free 
Krebs-Ringer. Calcium influx was stimulated by 
addition of 2 mM Ca2. (E) Values are mean  
SEM; n  number of cells from three different 
transfections. *P  0.0001.
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Treatment of cells with 75 M 2-aminoethyl diphenylbo-
rate (2-APB), a compound which has been reported to block
the InsP3R and calcium entry pathway (Bootman et al., 2002),
also blocked calcium influx into mock-transfected COS-7 cells
and cells transfected with the full-length junctate-EGFP con-
struct (Fig. 3, B and D), supporting the observation that the
increased receptor activated calcium entry observed in junctate
overexpressing cells relies on a PLC-dependent mechanism.
Junctate affects calcium entry stimulated by depletion 
of ER stores independently of receptor-coupled events
2-APB has been reported to block the calcium entry path-
ways activated either by receptor agonist-activation or by
store-depletion (Bootman et al., 2002). Therefore, we exam-
ined the effect of junctate on calcium entry mediated by de-
pletion of ER calcium stores. To ensure store depletion,
transfected COS-7 cells were loaded with 4 M indo-1/AM
in the presence of 1 mM EGTA (Fig. 4). This procedure de-
pletes intracellular calcium stores because addition of 50
M of the SERCA inhibitor t-BuBHQ (Fig. 4) failed to in-
duce a [Ca2]i transient. No difference in peak amplitude
calcium entry was observed between mock-transfected cells
and cells overexpressing either the NH2- or the COOH-ter-
minal domains of junctate. On the contrary, cells transfected
with the full-length junctate construct exhibited a 51  6%
increase (mean  SEM; n  48; *P  0.0001) of peak am-
plitude calcium entry compared with mock-transfected cells.
Junctate induces ER proliferation and an increase 
in frequency and extent of peripheral couplings
COS-7 cells transfected only with GFP show diffuse fluores-
cence in the cytoplasm (Fig. 5 A), whereas junctate-GFP
overexpressing COS-7 cells show an extensive GFP-positive
network that pervades the entire cytoplasm from the nucleus
to the cell periphery (Fig. 5, B and C). The channels respon-
sible for calcium entry in COS-7 cells have not been identi-
fied. Therefore, we investigated the effect of junctate overex-
pression in T3-HEK293 cells, a cell line of human origin,
which was transfected and stably expresses the TRPC3 cal-
cium entry channel (Zhu et al., 1998). This cellular model
has been exploited to test the conformational coupling hy-
pothesis of calcium entry predicting that a peripheral mem-
brane coupling between the ER membrane and the plasma
membrane is involved in activation of calcium entry (Irvine,
1990; Kiselyov et al., 2000).
The ultrastructure of junctate-GFP overexpressing T3-
HEK293 was compared with that of GFP-expressing T3-
HEK293 cells (controls) and of T3-HEK293 cells which
had been cotransfected with the reporter plasmid pEGFP
and depleted of their endogenous junctate using RNA inter-
ference (RNAi). Transfected cells were sorted with FACS®
on the basis of GFP expression. The underlying assumption
was that T3-HEK293 cells taking in the reporter plasmid
pEGFP were also taking in the RNAi construct. Control
cells (Fig. 5 D) and cells transfected with pShag-1-RNAi-
junctate construct have an active cell center with numerous
Golgi system profiles and isolated ER vesicles. Few ER pro-
files belonging to the continuous intracellular network are
seen elsewhere in the cell. By contrast, the cytoplasm of
junctate overexpressing cells contains a very extensive, laby-
rinthine ER, sometimes filling the entire cell (Fig. 5 E). The
ER profiles are quite clearly continuous with the nuclear en-
velope and reach all the way to the cell periphery. The rela-
tive extent of ER overdevelopment was roughly estimated by
classifying sectioned cell profiles on the basis of their content
of ER network, in areas other than the cell center, from al-
most nil to very extensive (Table I). Cells that were clearly in
the process of breakdown were not included in the counts.
Cells with moderate levels of ER may appear ER-free at one
section level, but have ER profiles elsewhere. However, cells
that have very extensive ER would show it at all section lev-
els. Table I shows that junctate overexpressing cells are more
highly represented than controls in the medium to extensive
Figure 5. Junctate-positive network in junctate overexpressing 
T3-HEK293 cells. (A) An example of a COS-7 cell transfected with 
GFP. The cell shows an amorphous cytoplasmic fluorescence. 
(B and C) Examples of COS-7 cells transfected with the full-length 
junctate-GFP. An extensive GFP-positive network extends from the 
perinuclear region throughout the cytoplasm. Approximately 25% 
junctate-GFP–positive COS-7 cells had the spindle-like appearance 
as shown in C. (D) GFP-transfected T3-HEK293 cells have a fairly 
extensive amount of smooth ER near the cell center (left portion of 
the image) but little of it elsewhere (at right). L, lysosome. (E) This 
junctate-GFP overexpressing cell exhibits a very extensive ER net-
work, continuous with the nuclear envelope and reaching out to the 
cell periphery. Such an extensive network was seen in a minority 
of cell profiles in sections from junctate-GFP expressing cells, but 
never in the control cells expressing GFP. Other cells from the same 
cultures show variable amounts of ER.
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ER content categories and pShag-1-RNAi-junctate–treated
cells have even less frequent ER profiles than the controls.
The ER network reaches from the nuclear envelope to the
cell periphery and forms junctional contacts (peripheral cou-
plings) with the plasma membrane, in which the two ap-
posed membranes run parallel to each other and are sepa-
rated by a small gap of fairly uniform width (Fig. 6). The ER
surface involved in the formation of these peripheral cou-
plings is somewhat variable, but usually fairly small in con-
trol T3-HEK293 cells (Fig. 6 A), in which sectioned profiles
of apposed ER are 218  94 nm long (n  165 measure-
ments; see Table II). The ER profiles of peripheral couplings
in junctate overexpressing cells are significantly longer and
more variable in length (339  192 nm; n  126; P 
0.0001, Table II) due to the presence of some large areas of
ER-plasma membrane junctional contact (Fig. 6, B–D). The
profiles of pShag-1-RNAi-junctate–treated cells are signifi-
cantly shorter than those in control cells (139  51 nm; n 
15; P  0.002; Table II). Note that in the latter case very
few junctions were measured because they are very scarce.
The frequency of peripheral couplings is also modulated by
the expression levels of junctate: pShag-1-RNAi-junctate–
treated cells show on the average 0.1 peripheral couplings/
cell profile; control cells have 0.5 peripheral couplings/cell
profile and junctate overexpressing cells have one peripheral
coupling/cell profile (Table II). Thus, the contacts between
the ER and the plasma membrane are dependent on the
level of expression of junctate; more frequent and extended
in junctate overexpressing cells and scarce and short when it
is expressed at very low levels.
Junctate modulates calcium entry via TRPC3 channels
We performed a set of experiments to gain insight into the
molecular and functional basis of the peripheral couplings in
T3-HEK293 cells. Microsomal membrane fractions from
T3-HEK293 cells contain a 33-kD integral membrane pro-
tein, which is identified as junctate because it is immunodec-
orated with antijunctate Ab (Fig. 7 A, lane 2). Because
TRPC3 interacts with the InsP3R and our data shows that
the InsP3R interacts with junctate, we investigated whether
junctate forms a complex with the TRPC3 channel. The
NH2-domain of junctate pulled down the TRPC3 channel
(Fig. 7 A, lane 4), whereas the corresponding scrambled pep-
tide was unable to do so (Fig. 7 A, lane 3). We then exam-
ined whether the InsP3R is also a component of the complex
by quantifying the junctate-InsP3R complex in HEK293
(i.e., wild-type cells) and in T3-HEK293 cells, by using a
peptide pull-down technique (Lund-Johansen et al., 2000;
see Fig. 7 B for a schematic representation of the experi-
ment). We found that when T3-HEK293 cell extracts were
used, there was a 3.6-fold increase in the association of
InsP3R to the beads coated with the peptide corresponding
to the NH2 terminus of junctate (Fig. 7 C). The presence of
the TRPC3 protein increased the geometric mean fluores-
cence intensity from a mean intensity of 386 for HEK293
cells to 776 for T3-HEK293 cells. In HEK293 cells, the
geometric mean fluorescence level generated by the NH2 ter-
minus of junctate is slightly higher compared with that ob-
tained when the beads were coated with an unrelated bio-
tinylated peptide (386 and 237, respectively). This result
reflects binding via endogenous TRPC3 channels, which
have been reported to be expressed endogenously at low lev-
els in wild-type HEK293 cells (Zhu et al., 1998).
The increase in fluorescent signal could be due to a higher
content of InsP3R in T3-HEK293 cells compared with that
of HEK293, or to an increase in the association between
TRPC3, InsP3R and junctate. To exclude the former possi-
bility, we performed Western blot analysis of the total soluble
extracts of HEK293 and T3-HEK293 cells with anti-type 3
InsP3R Ab. No appreciable changes in the quantity of InsP3R
expression was found between HEK293 and T3-HEK293
(Fig. 7 D) supporting the hypothesis that the presence of
Table I. ER statistics
Cell type
No. of 
experiments
Viable cell profiles
with no ER
Viable cell profiles
with minor ER
Viable cell profiles
with medium ER
Viable cell profiles
with extensive ER
Sorted GFP-expressing 
T3-HEK293 cells
1 (n  134 cells) 75% 20% 5% 0
Sorted GFP-junctate-expressing 
T3-HEK293 cells
2 (n  262 cells) 21% 40% 33% 6%
Sorted GFP-pShag-RNAi-junctate 
T3-HEK293 cells
1 (n  109 cells) 71% 29% 0 0
Figure 6. Overexpression of junctate results in 
larger peripheral couplings. The ER forms junctions 
with the plasma membrane (peripheral couplings, 
between arrows). The area of close apposition is 
smaller in the control (A) than in junctate over-
expressing (B–D) T3-HEK293 cells (see also Table II).
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TRPC3 channel protein, enforces the association of the su-
pramolecular complex. When extracts were incubated with
the unrelated biotinylated peptide the mean fluorescence in-
tensity was the same for HEK293 and T3-HEK293 cells
(237 and 236, respectively; Fig. 7 C, gray lines, unshaded his-
togram) and is due to nonspecific fluorescence of the FITC-
conjugated anti–goat antibodies binding to the beads.
On the basis of these data, we would expect that intracel-
lular perfusion in T3-HEK293 cells of the peptide encom-
passing the NH2 terminus of junctate would compete with
the endogenous junctate and affect calcium influx via the
TRPC3 channels. We performed patch clamp experiments
in the whole cell configuration on T3-HEK293 cells. Bath
application of 200 M of the muscarinic agonist carbachol
produced an inward current, previously characterized as
being mostly carried by TRPC3 channels (Hurst et al.,
1998). To test the effect of the NH2-domain of junctate,
the corresponding peptide (5 M) was introduced into
the pipette solution and allowed to diffuse into the cyto-
plasm for 8 min after establishment of the whole cell con-
figuration. Peptide dialysis produced a significant decrease
(70%; P  0.02; Fig. 7 G) of the peak inward current den-
sity induced by carbachol (Fig. 7 E). Fig. 7 (E and F)
shows representative recordings of inward current induced
by carbachol in control cells and in cells dialyzed with the
junctate peptide, respectively. It is important to note that
dialysis of peptide alone did not induce the appearance of
any current (Fig. 7 F). Furthermore, dialysis with the cor-
responding scrambled peptide (10 M) did not induce sig-
nificant changes of the inward current amplitude (not
Figure 7. A peptide encompassing the cytoplasmic 
domain of junctate complexes with the InsP3R via 
TRPC3 and inhibits TRPC3 current induced by 
carbachol in HEK293 cells stably expressing TRPC3. 
(A) Microsomal membrane fraction from T3-HEK293. 
Lane 1, Ponceau red staining; lane 2, antijunctate 
Ab immunostaining. Arrow indicates the band 
corresponding to junctate. The microsomal proteins 
of T3-HEK293 were solubilized, pulled down with 
Streptavidine beads coated either with a biotinylated 
peptide corresponding to the NH2 terminus of 
junctate (lane 4) or a biotinylated peptide corre-
sponding to the scrambled sequence of the NH2-
terminal domain of junctate (lane 3), and stained 
with anti–HA-tag Ab (lanes 3 and 4, respectively). 
(B) Model depicting the experimental approach 
used in C. (C) Peptide pull-down reactions analyzed 
by flow cytometry. Beads used in the pull down were 
coated with either an irrelevant peptide (gray lines, 
unshaded histograms) or junctate-derived peptide 
(shaded histograms). After incubation with cell 
lysates, beads were stained with goat anti-InsP3R 
type 3, followed by anti–goat IgG-FITC (x axis, log 
scale of geometric mean fluorescence intensity; 
y axis, number of events counted) and analyzed by 
flow cytometry. The geometric mean fluorescence 
intensity readout values are noted above each peak. 
(D) Immunoreactivity of total lysates prepared from 
HEK293 cells (lanes 1, 3, and 5) and T3-HEK293 
cells (lanes 2, 4, and 6). Total lysates from 5  104 
(lanes 1 and 2), 105 (lanes 3 and 4), and 1.5  105 
cells (lanes 5 and 6) were stained with anti-InsP3R 
type 3 Ab. (E–G) Cells were clamped at 40 mV 
and stimulated for 40 s with 200 M carbachol 
(CCh, black bar) 8 min after establishment of the 
whole cell configuration (t  0 min). Recordings of 
TRPC3 currents in control cells (E) and peptide dia-
lyzed cells (F). Histogram (G) showing mean  SD 
of control and peptide-treated current densities of 
seven different sets of experiments performed with 
wild-type HEK293 and T3-HEK293 cells. *P  0.02.
Table II. ER–plasma membrane junction (peripheral coupling) statistics
Cell type Average length of junction (mean  SD) No. of junctions/cell profile
(A) Sorted GFP-expressing T3-HEK293 cells 218  94 nm (n  165 junctions) 0.5/cell (n  112 cells)
(B) Sorted GFP-junctate–expressing T3-HEK293 cells 339  51 nm (n  126 junctions)* 1/cell (n  100 cells)**
(C) Sorted GFP-pShag-RNAi-junctate T3-HEK293 cells 139  51 nm (n  15 junctions)*** 0.1/cell (n  108 cells)****
t test: A versus B, *P  0.0001; A versus B, **P  0.007; A versus C, ***P  0.002; A versus C, ****P  0.009.
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depicted). Wild-type HEK293 cells showed negligible cur-
rent densities (0.05 pA/pF; Fig. 7 G).
Effect of junctate knockdown in T3-HEK293 cells
To investigate the role of endogenous junctate on [Ca2]i of
T3-HEK293 we cotransfected cells with the pShag-1 RNAi
construct and the reporter plasmid p enhanced YFP (EYFP).
Control cells were transfected with the pEYFP plasmid. From
both groups, YFP-positive cells were sorted (Fig. 8 A). In
RNAi-treated cells the mRNA encoding junctate was less
abundant than in pEYFP-transfected control cells (Fig. 8 B).
The presence of residual mRNA for junctate could be due ei-
ther to the presence of a small subpopulation of cells which
had been transfected only with the marker plasmid, or to the
inability of the construct to fully eliminate the expression of
junctate. The amount of -actin transcript did not differ be-
tween cells transfected with the two constructs (Fig. 8 B,
compare lanes 1 and 2 to lanes 3 and 4, top and bottom). De-
pletion of junctate in pShag-1-RNAi-junctate–treated cells
was also confirmed at the protein level by Western blot analy-
sis (Fig. 8 C). The RNAi construct we used specifically de-
graded the mRNA specific for junctate because (a) the level of
-actin mRNA was unchanged and (b) the expression of
other key proteins involved in calcium signaling such as the
InsP3R and the TRPC3 channel was not affected (Fig. 8 C).
We also performed an additional control to ensure the speci-
ficity of the RNAi protocol. In mammalian cells RNAi has
been reported to induce an interferon response, which leads
to nonspecific mRNA degradation (Sledz et al., 2003). We
tested for such a response in our cellular model by measuring
the production of 	 and  interferons. We did not observe
significant differences in the production of either interferon
in RNAi-treated T3-HEK293 cells (unpublished data).
Because in COS-7 cells junctate overexpression leads to al-
terations of intracellular calcium stores, we reasoned that de-
pletion of junctate would similarly affect intracellular cal-
cium pools. We assessed the releasable calcium of the stores,
by measuring the integral of the calcium signal induced by
50 M t-BuBHQ in both pEYFP-control and RNAi-treated
cells in the presence of 0.5 mM EGTA in the external me-
dium. Depletion of junctate induced a twofold decrease of
the releasable calcium by t-BuBHQ (Fig. 8 D). Next, we de-
termined whether knocking down junctate also affected cal-
cium entry induced by store depletion (Fig. 8 E, continuous
trace pEYFP-transfected cells; dashed trace RNAi-junctate–
treated cells). Intracellular calcium stores were first equally
and completely depleted by loading cells with fura-2/AM in
the presence of EGTA. This maneuver was effective in de-
pleting Ca2 stores because t-BUBHQ induced a negligible
calcium transient. pEYFP-transfected cells exhibited a large
calcium entry transient (Fig. 8 E, continuous line; Fig. 8 F,
unshaded box, mean peak calcium entry was 0.17  0.01
fluorescence units), whereas in pEYFP /pShag-1-RNAi-
junctate cotransfected cells, the transient was reduced near
to zero (Fig. 8 E, dashed line; Fig. 8 F, shaded box, mean
peak calcium entry was 0.04  0.008 fluorescence units;
P  0.00001).
To further substantiate the role of junctate on calcium sig-
naling, we also monitored the changes in [Ca2]i induced by
ATP in pShag-1-RNAi-junctate–transfected cells by study-
ing the [Ca2]i of single T3-HEK293 cells. Based on the
presence YFP expressing cells, we measured Ca2 fluxes in
groups of 5–10 cells. Stimulation of cells with 100 M ATP
induced a rapid and transient increase in [Ca2]i (Fig. 9, C
and I) which was reduced in T3-HEK293 cells in which en-
dogenous junctate had been knocked down. The decrease in
Figure 8. Transfection of T3-HEK293 cells with RNAi-junctate 
plasmid reduces the junctate transcript and protein level, affects 
intracellular store calcium content and diminishes store depletion-
mediated calcium entry. (A) 60 h after transfection cells were sorted 
and YFP-positive cells were selected; the boxed scattergram represents 
a typical experiment in which 33% of all sorted cells were YFP 
positive. The purity of the YFP-positive population of cells was 
90% 
as determined by reanalysis of the sorted cells by FACS® as well as 
fluorescence microscopy. (B) Total RNA was extracted from the YFP-
positive cells. RNA was converted into cDNA and semiquantitative 
RT-PCR was performed on 50 and 100 ng RNA. The figure is repre-
sentative of three different transfection experiments. (C) Total cellular 
protein extracts were prepared from the indicated number of YFP-
positive cells as described in the methods section. Proteins were stained 
with affinity-purified antijunctate antibodies, anti-HA antibodies, and 
anti-InsP3R antibodies. (D) Calcium content of the stores was deter-
mined by perfusing T3-HEK393 transfected with 50 M t-BuBHQ in 
nominally Ca2-free Krebs-Ringer; mean  SEM; n  cells from two 
transfections; a.u., arbitrary units. (E and F) YFP-positive T3-HEK293 
cells were selected and intracellular Ca2 measurements were per-
formed. (E) pEYFP-transfected (continuous line) and in pEYFPpShag-
RNAi-junctate–transfected cells (dashed line). (F) T3-HEK293 cells 
transfected with pEYFP (unshaded histogram) and pEYFPpShag-
RNAi-junctate (shaded histogram). Values are mean  SEM; 
n  number of cells from three different transfections.
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the amplitude of calcium release is evident not only in all the
cells cotransfected with the pEYFP, but also in two adjacent
cells which apparently did not pick up the pEYFP plasmid
(Fig. 9, G and I). This is probably due to the fact that trans-
fection efficiency is lower with larger plasmids, thus it is
likely that the cells which did not exhibit the YFP fluores-
cence were transfected with the smaller construct carrying
the RNAi cassette. Once the calcium signal returned to basal
level (Fig. 9, D and J) calcium entry was measured (Fig. 9, E
and K). Cells transfected with pEYFP alone exhibited a
larger agonist-activated calcium entry compared with cells
transfected with pShag-1-RNAi-junctate (Fig. 9 N).
Discussion
In the present paper, we investigated the role of junctate in
calcium homeostasis in eukaryotic cells. Our results suggest
that junctate plays an important role both in calcium release
after InsP3R activation and in calcium entry induced by ago-
nist-receptor activation and store depletion, perhaps by facil-
itating and/or stabilizing connections between the ER and
the plasma membrane.
Role of junctate in agonist-activated calcium release
The COOH-terminal domain of junctate is a moderate af-
finity, high capacity calcium binding domain. As expected,
overexpression either of the full-length protein or of the lu-
menal COOH-domain induces an increase in the amount of
releasable calcium from the stores sensitive to the SERCA
inhibitor t-BuBHQ. However, although overexpression of
full-length junctate also increases the amount of calcium re-
leased by ATP-mediated receptor activation, the COOH-
terminal domain does not. Thus, the COOH domain acts
similarly to calreticulin, a high capacity calcium binding
protein uniformly distributed within the lumen of the ER.
Overexpression of calreticulin increases the calcium content
of ER calcium stores, but does not affect InsP3-mediated cal-
cium release (Bastianutto et al., 1995; Xu et al., 2000).
The free calcium concentration in the endoplasmic reticu-
lum lumen has been calculated to be 500–600 M (Elliot,
2001). In the presence of physiological concentrations of
KCl, junctate binds calcium with an affinity of 217 M.
Thus, under resting conditions the calcium binding sites of
junctate are saturated by calcium. Our results clearly dem-
onstrate that in vivo junctate interacts with the InsP3R and
though we do not exactly know how many junctate binding
sites there are in the InsP3R complex, the simplest stoichio-
metric ratio is one junctate binding site per InsP3R complex.
This implies that under resting conditions one mole of the
junctate-InsP3R complex binds at least 21 moles of calcium
and these are adjacent to the inner leaflet of the ER mem-
brane. Thus, the moderate affinity calcium binding sites of
junctate are close to the lumenal mouth of the InsP3R and it
is tempting to speculate that an interaction between junc-
tate’s NH2 terminus and InsP3R causes a local increase of re-
leasable Ca2 upon agonist-receptor activation. This hy-
pothesis is in agreement with the results obtained by the
junctate RNAi experiments: knocking down junctate in-
duced a decrease in the amplitude of agonist-induced cal-
cium release. Measurements of [Ca2]ER during receptor-
mediated stimulation of calcium release have shown that the
amplitude of InsP3R-mediated calcium release declines to
near zero below a lumenal calcium concentration of 100
M (Barrero et al., 1997), and at such a free [Ca2]ER only
10% of junctate’s calcium binding sites would be occu-
pied (Treves et al., 2000). Under these conditions, the junc-
tate-associated calcium would be too low to drive further re-
lease of calcium via the InsP3R and would thus result in the
decline in calcium release, which has been experimentally
demonstrated.
These data suggest that the local releasable calcium adja-
cent to the lumenal mouth of the ER calcium release chan-
nel, as opposed to the global ER calcium content, is the ma-
Figure 9. Intracellular calcium measurements of T3-HEK293 cells 
depleted of junctate by RNAi. Ca2 measurements in fura-2 loaded 
T3-HEK293 cells were performed 60 h after transfection with pEYFP 
(A–F) and with pEYFPpShag-RNAi-junctate plasmids (G–L). (B and 
H) Resting [Ca2]i; (C and I) peak [Ca2]i after addition of 100 M 
ATP in nominally Ca2-free Krebs-Ringer; (D and J) [Ca2]i returned 
to resting level 25 s after addition of ATP; (E and K) calcium entry 
induced by replacement of EGTA-containing extracellular medium, 
to Krebs-Ringer containing 2 mM CaCl2, in the continuous presence 
of 100 M ATP; (F and L) [Ca2]i returned to resting levels by adding 
0.5 mM La3 to Krebs-Ringer containing 100 M ATP and 2 mM 
Ca2. Images were acquired at 340/380 nm and ratioed every 0.75 s. 
(M and N) Statistical analysis of mean (SEM) peak [Ca2]i induced 
by the addition of 100 M ATP and refilling of calcium pools induced 
by the readdition of 2 mM CaCl2 in YFP-transfected T3-HEK293 cells 
(unshaded histograms) and YFPRNAi-junctate–transfected cells 
(shaded histograms); n  number of cells analyzed. At least three 
different transfection experiments were performed and cells from two 
coverslips were analyzed per transfection experiment.
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jor limiting factor influencing InsP3-induced calcium release
events triggered by activation of surface receptors.
Role of junctate on calcium entry
The elucidation of store- and receptor-activated calcium en-
try has emerged as a major theme in the field of cellular sig-
naling in a variety of cell types. According to the conforma-
tional coupling hypothesis the InsP3R localized next to the
plasma membrane interacts with the calcium channel respon-
sible for calcium entry (Irvine, 1990; Kiselyov et al., 2000).
The membrane compartment containing the InsP3R and the
calcium entry channel may be endowed with other protein
components that could be involved in the calcium entry
mechanism. The ultrastructural and functional data reported
here not only support this model, but also identify junctate as
a candidate directly involved both in the assembly of the su-
pramolecular complex and in the modulation of its function.
In T3-HEK293 cells a small amount of ER extends through-
out the cytoplasm and approaches the plasma membrane,
where it forms discrete, small contacts with the plasma
membrane (peripheral couplings). In the presence of extra
amounts of junctate, the ER of T3-HEK293 cells is much
more extensive, and peripheral couplings are more frequent
and larger. Considering the dynamics of the ER, one likely
explanation is that the ER is continuously reaching toward
the plasma membrane and retracting from it and that junc-
tate either induces an association between the ER and the
plasma membrane or stabilizes it once it is formed. Coimmu-
noprecipitation and pull-down assay are consistent with such
a view and indicate that the molecular basis of the peripheral
coupling in T3-HEK293 cells is a heteroligomeric complex
formed by junctate, IP3R and TRPC3 channels.
In addition to an indirect role mediated by an increase in
peripheral couplings, our results suggest a more direct effect
of junctate on calcium entry and indicate that this role may
differ depending on how entry is elicited in an activated
cell. Modulation of receptor-activated calcium entry is af-
fected by the NH2 terminus of junctate, i.e., the domain of
the protein interacting with the InsP3R. This interaction is
not sufficient per se to modulate calcium entry, because the
PLC inhibitor U73122 blocked the modulatory effect. This
suggests that junctate affects receptor-activated calcium en-
try by modulating the steps which link the ligand-bound
InsP3R and the plasma membrane calcium channel. It is
plausible that initiation of the retrograde signal for stimula-
tion of the receptor-activated calcium entry requires ligand-
bound InsP3R. Binding of InsP3 to its receptor unmasks the
effect on calcium entry, which derives from the interaction
between the InsP3R and the NH2-terminal domain of junc-
tate. In contrast to receptor-activated calcium entry, modu-
lation of calcium entry induced by store depletion requires
the entire junctate molecule: the overexpression of either
the NH2-terminal domain or the COOH-terminal domain
does not modulate store-depletion activated calcium entry,
whereas it is significantly diminished in cells in which en-
dogenous junctate has been knocked down. The retrograde
signal activating store-depletion activated calcium entry is
probably initiated by the removal of the calcium bound to
the calcium binding domain of junctate, which is adjacent
to the lumenal mouth of the release channel. Such a signal
would be sensed by the calcium entry channel via the
ligand-free InsP3R.
In conclusion, our data demonstrate that junctate, a pro-
tein of sarco(endo)plasmic reticulum membranes, is a novel
component of the supramolecular machinery involved in
calcium entry.
Materials and methods
COS-7 and HEK293 cells were obtained from American Type Culture Col-
lection. Peroxidase-conjugated anti–mouse, anti–rat IgG, and protein-A
Sepharose were purchased from Sigma-Aldrich. Indo-1/AM, Fura-2/AM,
Mag-Fura-2/AM, and the calcium calibration kit were purchased from Mo-
lecular Probes. ATP, EDTA-free protease inhibitor cocktail tablets, anti-HA
antibodies, ECL reagents, and DNA modifying enzymes were purchased
from Roche Molecular Biochemicals. 2,5-Di(t-butyl)-1,4-hydroquinone
(t-BuBHQ), U73122, U73343, and 2-APB were purchased from Calbio-
chem. Streptavidin-conjugated Dynabeads were purchased from Dynal.
The pSilencer kit was purchased from Ambion. The pGex plasmid, glu-
tathione-Sepharose 4B, and nitrocellulose were purchased from Amer-
sham Biosciences. The pEGFP and pEYFP plasmids were purchased from
CLONTECH Laboratories, Inc. U6 RNA polymerase promoter pShag-1
vector was a gift of G. Hannon (Cold Spring Laboratories, Cold Spring Har-
bor, NY). Tissue culture reagents and Lipofectin were purchased from In-
vitrogen. Triton X-100, CaCl2, and La3 were purchased from Merck. Goat
anti-InsP3R Abs were purchased from Biosource International. Peroxidase-
conjugated protein A was purchased from Fluka. Streptavidin was pur-
chased from Southern Biotechnology Associates, Inc. Polystyrene latex
beads were purchased from Interfacial Dynamics Corporation. FITC-conju-
gated anti–goat IgG was purchased from BD Biosciences. All other chemi-
cals were reagent or highest available grade.
EGFP-junctate constructs
Junctate-EGFP, EGFP-junctate, and EYFP-junctate, were cloned into the
MCS of the pEGFPN3, pEGFPC1, and pEYFPC1 plasmids, respectively.
NH2-TM-EGFP and NH2-TM-EYFP, in which the first 85 aa of junctate, in-
cluding the transmembrane domain, were cloned into the MCS of
pEGFPN3 and pEYFPN3, respectively. EGFP-TM-COOH and EYFP-TM-
COOH in which the transmembrane and COOH domain of junctate were
cloned into the MCS of pEGFPC1 and pEYFPC1, respectively. For the latter
four constructs cDNA was amplified by PCR using the following forward
and reverse primers: 5-AGAATTCACAAATGGCTGAAG-3 and 5-GGG-
ATCCCTTTGCTTTGGCTAGA-3 for the NH2-TM-EGFP(EYFP) constructs;
and 5-GGAATTCCACCATGAGGAAAGGCGGACTCTCA-3 and 5-GAA-
GCTTTTAGGATCCTGGTG-3 for the EGFP (EYFP)-TM-COOH constructs.
All DNA constructs were checked by sequencing.
Expression of recombinant junctate in COS-7 cells and 
intracellular calcium measurements
Expression of GFP-junctate and single cell intracellular calcium measure-
ments in COS-7 cells were performed as described previously (Treves et al.,
2000). Measurements were made on cells from four distinct transfections.
RNAi for junctate with small double-stranded RNA
The RNAi oligo (5-GATCAAAAAAGTGTACCATTTCATGGAGGGAC-
TGAATTCAAGCTTCAATTCAGTCCCTTCTCCATGAAATGGTACG-3) was
annealed with equimolar amounts of the complementary oligo missing nu-
cleotides CG and GATC at the 5 and 3 ends, respectively. The annealed
oligos were subcloned into the U6 RNA pol III promoter pShag-1 vector.
The nucleotide sequence of the construct was verified by sequencing. RT-
PCR on YFP-positive cells using junctate specific primers (5-TCAAAAA-
GACTGCCCCTACC-3 and 5-GGACATGCAGGAATGTAACATGAC-3
for forward and reverse, respectively) or human -actin specific primers
(5-TGACGGGGTCACCCAC-3 and 5-CTAGAAGCATTGCGGT-3 for
forward and reverse, respectively). YFP-positive T3-HEK293 cells were
sorted in a FACSVantageTM SE sorter (model 621, Becton Dickinson; 488
nm Enterprise laser, filter 530/30).
For single cell intracellular measurements, transfected T3-HEK293 cells
were loaded with 5 M fura-2/AM; YFP-positive cells were identified using
an inverted microscope (model Axiovert S100 TV; Carl Zeiss MicroImag-
ing, Inc.) using a 40 Plan-Neofluar objective (NA  1.3) and filter (Carl
Zeiss MicroImaging, Inc.) set N44 (BP 475/40, FT 500, BP 530/50). Intra-
cellular calcium measurements were obtained using a 40 plan-Neofluar
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oil-immersion objective, at 340 and 380 nm excitation and 510 nm emis-
sion (filters BP 340/ BP 380; FT 425; 500–530). Fluorescence values ob-
tained at 340 and 380 nm were acquired with a multiformat CCD C4880-
80 camera (Hamamatsu), ratioed and the [Ca2]i was analyzed using an
Openlab imaging system. Calcium calibration was performed following
the instructions provided with the calcium calibration kit. The [Ca2]ER was
determined in cells loaded with 2 M Mag-Fura-2/AM as described by So-
lovyova et al. (2002).
Subcellular fractionation of HEK293
Subcellular fractions from T3-HEK293 cells stably transfected with the HA-
tagged TRPC channel protein (Zhu et al., 1998) were prepared as de-
scribed previously (Treves et al., 2000).
Coimmunoprecipitation and pull-down experiments
Total bovine cerebellum microsomal proteins (2 mg/ml) or integral mem-
brane proteins extracted from microsomes with 100 mM Na2CO3 as de-
scribed previously (Treves et al., 2000) were solubilized in: 1% Triton
X-100, 200 mM NaCl, and 50 mM Tris-HCl, pH 7.4, at RT for 60 min in
the presence of a protease inhibitor cocktail. Insoluble material was re-
moved by centrifugation. The solubilized fraction was diluted fivefold with
200 mM NaCl, and 50 mM Tris-HCl, pH 7.4. Affinity-purified polyclonal
antijunctate antibodies (Treves et al., 2000) were incubated with 200 g
solubilized bovine cerebellum microsomes for 2 h at RT, followed by incu-
bation with 30 l protein-A Sepharose. After 1 h, the beads were washed
three times with 200 mM NaCl, 50 mM Tris-HCl, pH 7.4; bound proteins
were separated on a SDS-PAG and blotted onto nitrocellulose.
For the pull-down experiments, microsomal proteins from T3-HEK293
cells, rabbit brain, and lung microsomes were washed with 0.6 M KCl, sol-
ubilized as described above, and incubated for 60 min with Streptavidin
beads coated with 10 g of a biotinylated peptide corresponding either to
the NH2 terminus of junctate or to its scrambled sequence, and GST–
COOH junctate. The beads were washed three times with 0.1% Triton
X-100, 200 mM NaCl, 1 mM EDTA, and 50 mM Tris-HCl, pH 7.4, and
Western blots of bound protein were stained with antibodies. GST–
COOH-terminal domain of junctate was prepared as described previously
(Treves et al., 2000). Protein concentration was measured as described
previously (Treves et al., 2000).
Electrophoresis and immunoblotting
SDS-PAGE, protein transfer onto nitrocellulose and immunostaining were
performed as described previously (Treves et al., 2000). Blots were probed
with a polyclonal anti-InsP3R, or monoclonal anti-InsP3R type 1, 2, and 3
antibodies (Sugiyama et al., 1994), with affinity-purified antijunctate Ab
(Treves et al., 2000) and anti-HA antibodies.
Electrophysiology
Recordings were performed on T3-HEK293 cells stably expressing TRPC3,
in the whole cell configuration of the patch clamp technique. The pipette
solution contained (mM) CaCl2 2, CsCl 120, EGTACs 5, Hepes 10, MgCl2
2, pH 7.2. Cells were bathed in Ringer’s solution containing (mM) NaCl
140, KCl 5.4, MgCl2 1, CaCl2 2, D-glucose 10, and Hepes 10, pH 7.4. Pi-
pettes (5–7 M
 were pulled from Kimax 51 glass (Kimball). Cells were
clamped with an Axopatch 200B amplifier (Axon Instruments) and currents
analyzed with pClamp 6.0. Current was filtered at 1 kHz. Holding poten-
tial was set at –40 mV.
Detection of peptide pull downs by flow cytometry
Streptavidin was covalently conjugated to 3.2-m-diam carboxylate-
modified polystyrene latex beads. The beads were then incubated in 150
mM NaCl, 10 mM Hepes, pH 7.4, for 30 min at RT with 100 g/ml biotin-
ylated peptide corresponding either to the NH2 terminus of junctate or an
irrelevant peptide (biotin-SHIPGLRPSQQQQL). After washing, the beads
were incubated with postnuclear lysates (150 mM NaCl, 50 mM Tris-HCl,
pH 8.0, 6 mM EDTA, 1% NP-40, 0.5% deoxycholate; Boulay et al., 1999)
from 2  105 HEK293 or T3-HEK293 cells for 60 min at RT. Beads were
washed and stained with goat anti-InsP3R type 3 and subsequently with
anti–goat IgG-FITC. Bead fluorescence was acquired on a FACScalibur cy-
tometer (Becton Dickinson Immunocytometry Systems); geometric mean
fluorescence intensity calculated using CellQuest software.
LM and EM analysis of GFP-junctate expressing cells
Transfected COS-7 cells were examined 48 h after transfection using an in-
verted microscope (model Diaphot 300; Nikon) equipped with a Plan-
Apo  100/1.4 oil-immersion objective under fluorescent light (excitation
480 nm; emission 510 nm) as described previously (Treves et al., 2000).
FACS-sorted GFP-positive T3-HEK293 cells were fixed in 3% glutaralde-
hyde in PBS and pelleted. The cells were maintained in the fixative for sev-
eral days. The pellets were fixed after in osmium tetraoxide, en-bloc
“stained” in uranyl acetate, and embedded. Thin sections showed 1–200
profiles of cells/section cut in random orientations. The section were
stained in uranyl acetate and lead containing solutions and examined in an
electron microscope (model 410; Philips).
Statistical analysis
Statistical analysis was performed using the t test for unpaired samples;
means were considered statistically significant when the P value was
0.05.
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